• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Cytori Therapeutics - Articles and news items

scleroderma

Cytori launches managed access programme for ECCS-50 for scleroderma

Industry news / 12 January 2016 / Victoria White

ECCS-50 is an autologous, adipose-derived cell therapy produced at the patient’s bedside and administered via a series of hand injections, in a single same-day procedure…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +